PHILIP FELIG, M.D.; WILLIAM V. TAMBORLANE, M.D.
This content is PDF only. Please click on the PDF icon to access.
Management of the insulin-dependent diabetic has long been characterized by debate between those advocating "tight" and those advocating "loose" control of blood glucose levels (1). Efforts to resolve this debate on the basis of retrospective or prospective evaluations of the effect of blood glucose control on the development of the long-term vascular and neurologic complications of diabetes have been inconclusive (2, 3). In recent years the focus has shifted from attempting to determine how diligent the patient, the physician, or both should be in applying conventional treatment to the development of newer forms of treatment such as islet cell transplantation
FELIG P, TAMBORLANE WV. Insulin Delivery Devices. Ann Intern Med. 1980;93:627–629. doi: 10.7326/0003-4819-93-4-627
Download citation file:
Published: Ann Intern Med. 1980;93(4):627-629.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use